Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Apr. 01, 2012		Apr. 03, 2011
Cash flows from operating activities:
Net loss	$ (74,530)		$ (2,121)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	12,541		13,163
Depreciation	29,071		25,697
Amortization of other intangible assets	2,782		7,064
Gain on sale of investments	0		(128)
Loss (gain) on mark-to-market derivatives	(13)		44
Non-cash interest expense	7,099		7,325
Amortization of debt issuance costs	1,019		1,256
Amortization of promissory notes	0		1,290
Third-party inventories write-down	9,045		0
Equity in earnings (loss) of unconsolidated investees	3,425		(7,133)
Deferred income taxes and other tax liabilities	(2,306)		(2,171)
Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable	87,672		52,274
Costs and estimated earnings in excess of billings	2,784		(40,638)
Inventories	(74,176)		(163,199)
Project assets	(39,027)		(27,644)
Prepaid expenses and other assets	(96,165)		(14,233)
Advances to suppliers	(15,724)		(12,820)
Accounts payable and other accrued liabilities	9,523		(26,368)
Billings in excess of costs and estimated earnings	(665)		21,271
Customer advances	1,016		(7,588)
Net cash used in operating activities	(136,629)		(174,659)
Cash flows from investing activities:
Decrease (increase) in restricted cash and cash equivalents	43,944		(4,728)
Purchase of property, plant and equipment	(32,782)		(44,757)
Proceeds from sale of equipment to third-party	416		209
Proceeds from sales or maturities of available-for-sale securities	0		300
Cash received for sale of investments in joint ventures	17,403		0
Cash paid for investments in joint ventures	0		(20,000)
Net cash provided by (used in) investing activities	28,981		(68,976)
Cash flows from financing activities:
Proceeds from issuance of bank loans, net of issuance costs	0		164,221
Repayment of bank loans and other debt	(100,592)		(156,136)
Repayments of Long-term Debt	100,592		156,136
Cash paid for repurchase of convertible debt	(198,608)		0
Proceeds from private offering of common stock, net of issuance costs	163,681		0
Cash distributions to Parent in connection with the transfer of entities under common control	(178,290)		0
Proceeds from exercise of stock options	8		73
Purchases of stock for tax withholding obligations on vested restricted stock	(3,885)		(8,077)
Net cash provided by (used in) financing activities	(317,686)		81
Effect of exchange rate changes on cash and cash equivalents	1,853		5,994
Net decrease in cash and cash equivalents	(423,481)		(237,560)
Cash and cash equivalents at beginning of period	725,618	[1]	605,420
Cash and cash equivalents, end of period	302,137		367,860
Non-cash transactions:
Property, plant and equipment acquisitions funded by liabilities	6,419		6,159
Non-cash interest expense capitalized and added to the cost of qualified assets	364		499
Issuance of warrants in connection with the Liquidity Support Agreement	$ 50,327		$ 0

[1] As adjusted to reflect the balances of Tenesol S.A. ("Tenesol") beginning October 10, 2011, as required under the accounting guidelines for a transfer of an entity under common control (see Note 3).